Bloodreserving technology during surgical treatment of mitral valve disease

  • V. V. Popov National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • B. N. Gumenyuk National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • A. M. Gurtovenko National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • V. L. Dyachenko National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • L. I. Tihonenko National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • E. V. Rudenko National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
  • V. V. Lazorishinetz National M. M. Amosov Institute of Cardiovascular Surgery National Academy of Medical Sciences of Ukraine
Keywords: cardiopulmonary bypass, method without using donor blood, correction of mitral valve

Abstract

Usage of donor blood during operations of mitral valve replacement with usage of donor blood components is associated with different possible complications, which stimulates to search measures for not using ше. In department of acquired heart diseases of NICVS AMS Ukraine from 01.01.2006. till 01.01.2009 were performed 317 isolated mitral valve replacements, in treatment of whom during hospital period components of donor blood were not used. Methodics of anesteological and perfusiological treatment in mitral valve replacemnt with cardiopulmonary bypass was described, and alsopeculiarities in intensive care unit. Hospital mortality was 1,4%, duration of stay in intensive care unit 54,2±4,7 hours, duration of stay in surgical department – 7,9±0,7 days. At discharge this group of patients had moderate anemia. Usage of developed methodics in clinical practice allowed to get good clinical effect, avoiding posttransfusion complications on hospital stage.

References

1. Лазоришинец В. В., Попов В. В. Кровосберегающие технологии при хирургическом лечении митрального порока. – К., 2015. – С. 167.

2. Engoren M., Schwan T. A., Habib R. H., Neil C. V. The independent effect of anemia and transfusion on mortality after coronary bypass // Annals of Thoracic Surgery. – 2014. – Vol. 97. – P. 514–520.

3. Is postoperative blood loss, loss of blood? A pilot study in cardiac surgical patients / E. J. Fransen, D. S. de Jong, W. T. Hermens, J. G. Maessen // Perfusion. – 2001. – Vol. 16, № 4. – P. 301–308.

4. Williams M. І. et al. Preoperative hematocrit is a powerfull predictor of adverse outcomes in coronary surgery // Ann Thor. Surg. – 2013. – Vol. 96. – P. 1628–1634.

5. Handbook of Transfusion Medicine / Editor D B L McClelland. – London : TSO, 2007. – P. 15, 26–27, 31.

6. Heiss M. M. Immunosuppression and Transfusion / M. M. Heiss // TATM Journal. – 2000. – Vol. 3. – P. 26–31.

7. Engoren M. et al. Is transfusion associated with graft occlusion after cardiac operations? // Annals of Thoracic Surgery. – 2015. – Vol. 99. – P. 502–508.

8. Bhaskar B. et al. Impact of blood product transfusion on short and long-term survival after cardiac operations // Annals of Thoracic Surgery. – 2012. – Vol. 94. – P. 469–467.

9. Lewis C. E. et al. Autologous blood transfusion in elective cardiac valve operations // J. Card. Surg. – 2005. – Vol. 20. – P. 513–518.

10. Nydegger U. Transfusion dependency in cardiac surgery update 2006 / U. Nydegger // Swiss Med. Wkly. – 2006. – Vol. 136. – P. 781–788.

11. Spiess B. D. et al. Perioperative blood transfusion and blood conservation in cardiac surgery // Annals of Thoracic Surgery. – 2007. –Vol. 83. – P. 27–86.
Published
2016-12-02
How to Cite
Popov, V. V., Gumenyuk, B. N., Gurtovenko, A. M., Dyachenko, V. L., Tihonenko, L. I., Rudenko, E. V., & Lazorishinetz, V. V. (2016). Bloodreserving technology during surgical treatment of mitral valve disease. Ukrainian Journal of Cardiovascular Surgery, (3 (26), 44-50. Retrieved from https://cvs.org.ua/index.php/ujcvs/article/view/201
Section
ACQUIRED HEART DISEASES